<table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl2" position="float"><object-id pub-id-type="doi">10.7554/eLife.04640.027</object-id><label>Table 2.</label><caption><p>Drug resistance is overcome as the IC50 (cell viability) approaches the IC50 (target phosphorylation)</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04640.027">http://dx.doi.org/10.7554/eLife.04640.027</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>JQ1</th><th>MEKi</th><th>RAFi</th></tr></thead><tbody><tr><td>IC50 (target phosphorylation)</td><td>&#8211;</td><td>3 nM<xref ref-type="table-fn" rid="tblfn2">*</xref></td><td>65 nM<xref ref-type="table-fn" rid="tblfn2">*</xref></td></tr><tr><td>IC50 (cell viability) single agent</td><td>200 nM</td><td>15 nM</td><td>&gt;1 &#956;M</td></tr><tr><td>IC50 (cell viability) combined with JQ1</td><td>&#8211;</td><td>5 nM<xref ref-type="table-fn" rid="tblfn3">&#8224;</xref></td><td>120 nM<xref ref-type="table-fn" rid="tblfn3">&#8224;</xref></td></tr></tbody></table><table-wrap-foot><fn id="tblfn2"><label>*</label><p>MEKi targets pERK and RAFi targets pMEK. Phopho-IC50s are quantified from gels (<xref ref-type="fig" rid="fig6">Figure 6B</xref>).</p></fn><fn id="tblfn3"><label>&#8224;</label><p>IC50s for viability and phosphorylation are in same order.</p></fn></table-wrap-foot></table-wrap>